inforMED
MalfunctionJTO

VITEK® 2 NH TEST KIT

Received Feb 7, 2017

Report 1950204-2017-00045 · MDR key 6309212

Device

Generic name

Vitek® 2 Nh Test Card

Manufacturer

Biomerieux, Inc

Catalog number

21346

Lot number

245350210

Product problems

  • Incorrect Or Inadequate Test Results
  • Incorrect Or Inadequate Test Results

Patient

Not reported

  • No Known Impact Or Consequence To Patient
  • No Known Impact Or Consequence To Patient

Narrative

Additional Manufacturer Narrative

A CUSTOMER REPORTED A MISIDENTIFICATION OF A NEISSERIA ORALIS STRAIN AS NEISSERIA MENINGITIDIS IN ASSOCIATION WITH THE VITEK® 2 NEISSERIA-HAEMOPHILUS (NH) ID TEST KIT ((B)(4)). THE CUSTOMER SUBMITTED THE ISOLATE FOR EVALUATION. AN INVESTIGATION WAS PERFORMED. THE SUBMITTED ISOLATE WAS SUBCULTURED AND NH TESTING INCLUDED TWO CARDS FROM TWO RANDOM LOTS, AS THE CUSTOMER'S LOT WAS EXPIRED. THE 16S SEQUENCING WAS ALSO PERFORMED. A VERY GOOD IDENTIFICATION OF NEISSERIA MENINGITIDIS WAS OBTAINED TWICE AND LOW DISCRIMINATION IDENTIFICATION OF N. CINEREA/N. MENINGITIDIS/N. SICCA, TWICE, DUPLICATING THE CUSTOMER'S RESULTS. THE 16S SEQUENCING RESULTED IN 99% IDENTITY MATCH AS NEISSERIA ORALIS. THE PRODUCT INFORMATION STATES TESTING OF UNCLAIMED SPECIES MAY RESULT IN AN UNIDENTIFIED RESULT OR A MISIDENTIFICATION. NEWLY DESCRIBED OR RARE SPECIES MAY NOT BE INCLUDED IN THE NH DATABASE. SELECTED SPECIES WILL BE ADDED AS STRAINS BECOME AVAILABLE. NEISSERIA ORALIS IS NOT A CLAIMED SPECIES FOR THE VITEK® 2 NH CARD.

Description of Event or Problem

A CUSTOMER IN (B)(6) REPORTED TO BIOMÉRIEUX A MISIDENTIFICATION OF NEISSERIA ORALIS AS NEISSERIA MENINGITIDES IN ASSOCIATION WITH THE VITEK® 2 NH TEST KIT. THE STRAIN WAS ISOLATED FROM CHOCOLATE AGAR AND TESTED THREE TIMES WITH VITEK® 2 NH WHICH IDENTIFIED THE ISOLATE AS NEISSERIA MENINGITIDES. THE NEISSERIA ORALIS IDENTIFICATION WAS OBTAINED BY 16S RRNA FULL SEQUENCING. THE CUSTOMER ALSO TESTED THE ISOLATE WITH VITEK® MS AND OBTAINED A RESULT OF NEISSERIA MUCOSA. THERE IS NO INDICATION OR REPORT FROM THE HOSPITAL OR TREATING PHYSICIAN TO BIOMÉRIEUX THAT THE DISCREPANT RESULT LED TO ANY ADVERSE EVENT RELATED TO THE PATIENT'S STATE OF HEALTH. THE TEST REPORTS WERE REQUESTED FROM THE CUSTOMER. AN INTERNAL BIOMÉRIEUX INVESTIGATION HAS BEEN INITIATED.